← Open Payments lookup

RANETTE HARRINGTON: Open Payments

NPI 1093407090 · NOTTINGHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,350 in 62 payments from 11 companies in 2025. Trend: 2023 $326 · 2024 $1,393 · 2025 $1,350

Food & beverage: $1,350
CompanyPaymentsAmount
ABBVIE INC.21$392
Teva Pharmaceuticals USA, Inc.12$338
Supernus Pharmaceuticals, Inc.9$202
Vanda Pharmaceuticals Inc.6$120
Lundbeck LLC5$78
Neurocrine BioSciences, Inc.2$57
Otsuka America Pharmaceutical, Inc.2$47
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46
Almatica Pharma LLC1$28
Bausch Health US, LLC1$24

Products named: VRAYLAR, UZEDY, Qelbree, HETLIOZ, REXULTI, INGREZZA, ABILIFY MAINTENA, CAPLYTA.

Industry payments across MD — which companies pay providers there.